← Back to Search

Dietary Fiber

Cereal with Beta Glucan for Healthy Subjects

N/A
Waitlist Available
Led By Thomas Wolever, DM, PhD
Research Sponsored by Société des Produits Nestlé (SPN)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up glucose will be measured over 2 hours postprandially (timepoints: -5, 0, 15, 30, 45, 60, 90, and 120 minutes)
Awards & highlights

Study Summary

This trial will test whether 1.4g of either oat or barley beta-glucan can significantly reduce postprandial glycemic response compared to no beta-glucan.

Who is the study for?
This trial is for non-pregnant, non-lactating individuals aged 20-65 with a BMI of 18.0 to 29.9 kg/m² and normal fasting glucose levels. Participants should be nonsmokers, willing to follow the study protocol, abstain from certain activities before study days, and provide informed consent. They must not have had major medical events recently or plan COVID-19 vaccination during the study.Check my eligibility
What is being tested?
The trial tests if cereals enriched with lower amounts of β-glucan (1.4-1.5g) from barley or oats can significantly reduce blood sugar spikes after eating compared to regular cereal without β-glucan in healthy adults.See study design
What are the potential side effects?
Since the intervention involves dietary fiber enrichment in cereals, side effects may include digestive changes such as bloating or gas but are generally expected to be minimal given that β-glucan is a natural component found in common foods.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~glucose will be measured over 2 hours postprandially (timepoints: -5, 0, 15, 30, 45, 60, 90, and 120 minutes)
This trial's timeline: 3 weeks for screening, Varies for treatment, and glucose will be measured over 2 hours postprandially (timepoints: -5, 0, 15, 30, 45, 60, 90, and 120 minutes) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Postprandial Glucose Incremental Area under the Curve (iAUC) from 0-2 hours
Secondary outcome measures
Glucose
Gmax
Imax
+6 more

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: OBG CerealExperimental Treatment1 Intervention
A portion of cereal (25g available carbohydrate) that contains approximately 1.4g of oat beta-glucan (OBG)
Group II: BBG CerealExperimental Treatment1 Intervention
A portion of cereal (25g available carbohydrate) that contains approximately 1.4g of barley beta-glucan (BBG)
Group III: Control CerealPlacebo Group1 Intervention
A portion of cereal (25g available carbohydrate) that contains no beta-glucan

Find a Location

Who is running the clinical trial?

INQUIS Clinical Research Ltd.Industry Sponsor
7 Previous Clinical Trials
253 Total Patients Enrolled
Société des Produits Nestlé (SPN)Lead Sponsor
337 Previous Clinical Trials
62,519 Total Patients Enrolled
INQUIS Clinical ResearchIndustry Sponsor
9 Previous Clinical Trials
283 Total Patients Enrolled

Media Library

Cereals Enriched with β-glucan (Dietary Fiber) Clinical Trial Eligibility Overview. Trial Name: NCT05556837 — N/A
Healthy Subjects Research Study Groups: Control Cereal, OBG Cereal, BBG Cereal
Healthy Subjects Clinical Trial 2023: Cereals Enriched with β-glucan Highlights & Side Effects. Trial Name: NCT05556837 — N/A
Cereals Enriched with β-glucan (Dietary Fiber) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05556837 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Effect of Extruded Cereals Enriched With β-glucan on Postprandial Plasma Glucose and Serum Insulin Responses
2024. "Effect of Extruded Cereals Enriched With β-glucan on Postprandial Plasma Glucose and Serum Insulin Responses". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05556837.
~28 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top